Norms Impact
There’s no Tylenol, autism link and RFK Jr. seems to know it | Opinion
Our top federal health officials leveraged the authority of FDA and HHS to amplify an unproven autism claim, then walked it back—eroding the public’s baseline trust in government health guidance.
Sources
Summary
Health and Human Services Secretary Robert F. Kennedy Jr. said there is “not sufficient” evidence to say Tylenol use during pregnancy “definitely causes autism,” after previously promoting the claim publicly with President Donald Trump. The executive branch used the posture of federal health authority to float a purported FDA notice, labeling change, and nationwide campaign tied to an asserted autism “answer,” then retreated to uncertainty. The practical consequence is widespread public belief in a medically unsupported claim, with polling showing substantial uptake among parents and Republicans, and a state attorney general lawsuit now leaning on that same federal messaging.
Reality Check
This kind of conduct weaponizes federal health authority against the public’s right to reliable, evidence-based guidance, and it normalizes policy-by-press-conference that can steer families’ medical decisions through fear. On the record here, the core legal exposure is less about a clean criminal fit and more about a profound abuse of public office: there’s no showing of fraud elements like material misrepresentations to obtain money or property under federal wire fraud (18 U.S.C. § 1343), but the pattern still corrodes democratic stability by turning agencies into megaphones for “suggestive” claims. When the executive branch signals FDA label changes and national campaigns on a premise the same secretary later concedes is not sufficient, our institutions become unreliable—and citizens, especially pregnant patients and parents, pay the price.
Detail
<p>On Sept. 22, President Donald Trump and HHS Secretary Robert F. Kennedy Jr. held a news conference Trump billed as presenting “an answer to autism.” Trump said Tylenol is “associated with a very increased risk of autism,” and Kennedy said the FDA would issue a physician’s notice about acetaminophen risk during pregnancy, begin a safety label change process, and that HHS would launch a nationwide public service campaign.</p><p>On Oct. 9, during a Cabinet meeting, Kennedy said people who take acetaminophen during pregnancy “unless they have to” are “irresponsible,” and referenced studies he claimed involved circumcision and autism rates tied to Tylenol. On Oct. 29, Kennedy said the “causative association” between Tylenol in pregnancy and the perinatal period is “not sufficient” to say it “definitely causes autism.”</p><p>A KFF tracking poll found 77% of Americans had heard the claim; among parents, 36% said it was probably true, and among Republicans, 50% did. On Oct. 28, Texas Attorney General Ken Paxton filed suit against Tylenol makers asserting federal confirmation of causation.</p>